Literature DB >> 6838909

Oxalate synthesis from [14C1]glycollate and [14C1]glyoxylate in the hepatectomized rat.

M P Farinelli, K E Richardson.   

Abstract

Hepatectomy significantly altered the metabolism of [1-14C]glyoxylate and [1-14C]glycollate in the rat. The production of 14CO2 was reduced by 47% and 77-86%, respectively, indicating the involvement of the liver in the oxidation of both substrates. Unidentified intermediates, assumed to be primarily glycine, serine and ethanolamine, were also reduced by over 50%, as would be expected from the removal of the aminotransferase enzymes through the hepatectomy. The biosynthesis of [14C]oxalate from [1-14C]glycollate was reduced by more than 80% in the hepatectomized rat. This suggests that this oxidation is primarily catalyzed by the liver enzymes, glycolic acid oxidase and glycolic acid dehydrogenase, in the intact rat. The limited formation of [14C]oxalate from [14C1]glycollate observed in the hepatectomized rat is probably catalyzed by lactate dehydrogenase or extrahepatic glycolic acid oxidase. Hepatectomy did not significantly alter the rate of formation of [14C]oxalate from [14C1]glyoxylate. However, since saturating concentrations of glyoxylate could not be used because of the toxicity of this substrate, the involvement of glycollic acid oxidase in this oxidation reaction in the intact rat can not be ruled out. In the hepatectomized rat, lactate dehydrogenase appears to be the enzyme making the major contribution, although other as yet not identified enzymes may be contributing. The increased deposition of oxalate in the tissues, oxalosis, may result from the shift in oxalate synthesis from the liver to the extrahepatic tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838909     DOI: 10.1016/0304-4165(83)90146-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.

Authors:  Xingsheng Li; John Knight; Sonia Fargue; Brianna Buchalski; Zhengrong Guan; Edward W Inscho; Abigail Liebow; Kevin Fitzgerald; William Querbes; W Todd Lowther; Ross P Holmes
Journal:  Biochim Biophys Acta       Date:  2015-12-02

2.  Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells.

Authors:  Joseph T Behnam; Emma L Williams; Susanne Brink; Gill Rumsby; Christopher J Danpure
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

Review 3.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

Review 4.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

Review 5.  Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.

Authors:  Joseph J Crivelli; Tanecia Mitchell; John Knight; Kyle D Wood; Dean G Assimos; Ross P Holmes; Sonia Fargue
Journal:  Nutrients       Date:  2020-12-28       Impact factor: 5.717

6.  In female rats, ethylene glycol treatment elevates protein expression of hepatic and renal oxalate transporter sat-1 (Slc26a1) without inducing hyperoxaluria.

Authors:  Davorka Breljak; Hrvoje Brzica; Ivana Vrhovac; Vedran Micek; Dean Karaica; Marija Ljubojević; Ankica Sekovanić; Jasna Jurasović; Dubravka Rašić; Maja Peraica; Mila Lovrić; Nina Schnedler; Maja Henjakovic; Waja Wegner; Gerhard Burckhardt; Birgitta C Burckhardt; Ivan Sabolić
Journal:  Croat Med J       Date:  2015-10       Impact factor: 1.351

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.